Coty Inc. — FY2021 Form 10-K Summary
Period clarification: The filing is the annual report for the fiscal year ended June 30, 2021, not a 2020 Q4 filing. It also reports quarterly results for the three months ended June 30, 2021. Dollar amounts are in millions unless otherwise stated.
Business context and reporting period
Coty sells fragrances, color cosmetics, and skin and body care in approximately 130 countries. Continuing operations were reported in Americas, EMEA, and Asia Pacific segments. The company plans to move to prestige and consumer beauty segments beginning in fiscal 2022. In November 2020, Coty sold a majority stake in its Wella Professional and Retail Hair business, retained a 40% interest, and presented Wella as discontinued operations.
Key financial results
| Metric | FY2021 | FY2020 |
|---|---|---|
| Continuing-operations net revenue | $4,629.9 | $4,717.8 |
| Gross profit / gross margin | $2,768.2 / 59.8% | $2,726.6 / 57.8% |
| Operating loss | $(48.6) | $(1,236.5) |
| Net loss from continuing operations | $(67.8) | $(1,089.9) |
| Net loss attributable to Coty Inc. | $(201.3) | $(1,006.7) |
| Adjusted operating income (non-GAAP) | $409.4 | $(161.7) |
| Adjusted EBITDA (non-GAAP) | $760.4 | $174.6 |
| Operating cash flow | $318.7 | $(50.9) |
| Capital expenditures | $173.9 | $267.4 |
| Cash and cash equivalents at year-end | $253.5 | $308.3 |
| Total debt at year-end | $5,481.5 | $8,156.3 |
FY2021 revenue fell 2% year over year; excluding acquisition and divestiture effects, it declined 2%, with a 3% volume decrease partly offset by 2% favorable currency translation and a 1% adverse price-and-mix effect. Gross margin expanded about 200 basis points. The improved operating result reflected lower costs and no goodwill or indefinite-lived intangible impairment charge, versus $434.0 of impairment charges in FY2020. Adjusted measures are non-GAAP and should be considered alongside GAAP results.
FY2021 operating cash flow less capital expenditures was approximately $144.8, calculated from the reported figures. Cash and restricted cash totaled $310.4 at year-end. Current assets were $1,783.1 and current liabilities were $2,415.4. Debt fell substantially following the Wella transaction and related repayments; Coty also issued secured notes due 2026 to refinance term debt. The company reported compliance with its debt covenants at June 30, 2021.
In the fourth quarter, continuing-operations revenue was $1,062.4 and operating income was $1.8. Coty reported a continuing-operations net loss of $201.4 and a net loss attributable to Coty Inc. of $186.0. The quarter included a $132.9 income-tax provision.
Material changes versus the prior period
- Revenue declined modestly from FY2020, while operating performance, adjusted EBITDA, and operating cash flow improved markedly.
- Gross margin rose to 59.8% from 57.8%; SG&A declined to $2,363.2 from $3,120.0, reflecting cost reductions and lower advertising and promotional spending.
- Debt declined by approximately $2.7 billion. Wella sale proceeds included $2,451.7 in cash for the majority stake, and Coty used $2,015.5 of net proceeds to repay term facilities. Coty retained a Wella investment valued at $1,260.0 at year-end.
- FY2021 included a $246.4 loss on the Wella sale in discontinued operations. Wella contributed five months of FY2021 operating results before the sale closed.
- Common-stock dividends remained suspended; Coty paid $24.2 of cash dividends on its Series B preferred stock for the quarter ended June 30, 2021.
Outlook, commentary, risks, and unusual items
- Management said the recovery from COVID-19 would be gradual and uneven, with continuing uncertainty for color cosmetics, travel retail, and consumer demand. It cited signs of recovery, particularly in prestige fragrance, e-commerce, and China.
- The Transformation Plan targets revenue stabilization and growth, gross-margin improvement, cost control, a more agile operating model, digital expansion, and debt reduction. Coty expected approximately $200 of additional cash costs in FY2022 and FY2023, $100 below its previously announced aggregate estimate. It reported higher-than-anticipated savings exiting FY2021 but did not quantify future savings in this excerpt.
- The company gave no specific revenue or earnings guidance in the provided filing text. It expects to continue cost-reduction initiatives and said it believes liquidity and covenant headroom are sufficient for foreseeable operating and recurring cash needs.
- Other unusual financial items included a $234.4 tax benefit related to relocating the principal location from Geneva to Amsterdam and a $130.0 tax expense for post-Wella internal restructuring. Coty also recorded a $73.5 unrealized gain on its retained Wella investment.
- Brazilian tax assessments totaled approximately $328.5, including interest and penalties. Coty is contesting them, has not recorded a loss because it does not consider one probable, and cannot rule out further assessments. Other disclosed litigation includes shareholder suits and product-liability claims, including talc-related matters; loss estimates for certain cases were not available or could not be reasonably estimated.
- Impairment remains a valuation risk: Max Factor’s estimated fair value exceeded carrying value by only 3.3% at the annual test date. Coty cautioned that changes in forecasts, discount rates, or market conditions could lead to future charges.
- The CEO received a one-time restricted-stock award expected to generate approximately $273.2 of compensation expense over its vesting period, mostly in FY2022 and FY2023. Coty’s 9% Series B preferred dividend accrues and can increase if unpaid; accrued preferred dividends restrict cash dividends on common stock.
Important facts for investors to verify
- Review the full audited statements and debt note for maturity, interest-rate, covenant, and refinancing terms; the company had $5.48 billion of debt against $253.5 million of cash.
- Track continuing-operations revenue and volume recovery by category and geography, particularly color cosmetics, prestige fragrance, travel retail, and China; assess the planned segment realignment.
- Assess whether gross-margin gains, cost savings, and adjusted profitability persist as advertising and promotional spending normalizes, while distinguishing non-GAAP results from GAAP losses.
- Verify final Wella sale working-capital and purchase-price adjustments, the value and performance of the retained 40% stake, and the duration and economics of the transition-services arrangement.
- Monitor Transformation Plan cash costs and savings, the Series B dividend burden and common-dividend restrictions, and the potential dilution associated with preferred-stock conversion.
- Follow developments in Brazilian tax assessments, shareholder and product-liability litigation, and Max Factor impairment assumptions.